X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with WYETH LTD - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs WYETH LTD - Comparison Results

WYETH LTD 
   Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB WYETH LTD UNICHEM LAB/
WYETH LTD
 
P/E (TTM) x -33.1 27.7 - View Chart
P/BV x 0.7 5.3 13.4% View Chart
Dividend Yield % 2.4 1.3 185.1%  

Financials

 UNICHEM LAB   WYETH LTD
EQUITY SHARE DATA
    UNICHEM LAB
Mar-18
WYETH LTD
Mar-13
UNICHEM LAB/
WYETH LTD
5-Yr Chart
Click to enlarge
High Rs3821,044 36.6%   
Low Rs234818 28.6%   
Sales per share (Unadj.) Rs116.3298.6 39.0%  
Earnings per share (Unadj.) Rs-18.957.2 -33.1%  
Cash flow per share (Unadj.) Rs-11.758.4 -20.1%  
Dividends per share (Unadj.) Rs5.0017.00 29.4%  
Dividend yield (eoy) %1.61.8 88.9%  
Book value per share (Unadj.) Rs381.0249.5 152.7%  
Shares outstanding (eoy) m70.3422.72 309.6%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.63.1 84.9%   
Avg P/E ratio x-16.316.3 -100.1%  
P/CF ratio (eoy) x-26.215.9 -164.6%  
Price / Book Value ratio x0.83.7 21.7%  
Dividend payout %-26.429.7 -89.0%   
Avg Mkt Cap Rs m21,66821,157 102.4%   
No. of employees `0002.30.5 463.4%   
Total wages/salary Rs m2,006400 501.6%   
Avg. sales/employee Rs Th3,587.813,787.4 26.0%   
Avg. wages/employee Rs Th880.0813.0 108.2%   
Avg. net profit/employee Rs Th-583.72,643.3 -22.1%   
INCOME DATA
Net Sales Rs m8,1806,783 120.6%  
Other income Rs m610353 173.0%   
Total revenues Rs m8,7907,136 123.2%   
Gross profit Rs m-1,3201,617 -81.6%  
Depreciation Rs m50527 1,898.9%   
Interest Rs m806 1,456.4%   
Profit before tax Rs m-1,2951,938 -66.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m0-5 0.0%   
Tax Rs m33632 5.3%   
Profit after tax Rs m-1,3311,301 -102.3%  
Gross profit margin %-16.123.8 -67.7%  
Effective tax rate %-2.632.6 -7.9%   
Net profit margin %-16.319.2 -84.9%  
BALANCE SHEET DATA
Current assets Rs m23,3186,984 333.9%   
Current liabilities Rs m4,6352,056 225.5%   
Net working cap to sales %228.472.6 314.4%  
Current ratio x5.03.4 148.1%  
Inventory Days Days12299 122.7%  
Debtors Days Days12124 507.4%  
Net fixed assets Rs m8,163244 3,341.5%   
Share capital Rs m141227 61.9%   
"Free" reserves Rs m26,6605,441 490.0%   
Net worth Rs m26,8015,668 472.8%   
Long term debt Rs m325 13.2%   
Total assets Rs m31,8907,901 403.6%  
Interest coverage x-15.2353.3 -4.3%   
Debt to equity ratio x00 2.8%  
Sales to assets ratio x0.30.9 29.9%   
Return on assets %-3.916.5 -23.7%  
Return on equity %-5.022.9 -21.6%  
Return on capital %-4.534.0 -13.3%  
Exports to sales %00.2 0.0%   
Imports to sales %036.3 0.0%   
Exports (fob) Rs mNA15 0.0%   
Imports (cif) Rs mNA2,465 0.0%   
Fx inflow Rs m4,35615 28,660.5%   
Fx outflow Rs m02,677 0.0%   
Net fx Rs m4,356-2,662 -163.7%   
CASH FLOW
From Operations Rs m-1,123923 -121.7%  
From Investments Rs m16,487317 5,202.5%  
From Financial Activity Rs m-8,811-481 1,831.9%  
Net Cashflow Rs m6,552759 863.1%  

Share Holding

Indian Promoters % 50.1 0.0 -  
Foreign collaborators % 0.0 51.1 -  
Indian inst/Mut Fund % 15.1 11.3 133.6%  
FIIs % 3.0 7.2 41.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 30.4 104.3%  
Shareholders   20,176 21,978 91.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   WOCKHARDT LTD.  J.B.CHEMICALS  MERCK LTD  DIVIS LABORATORIES  FULFORD INDIA  

Compare UNICHEM LAB With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 118 Points Higher; Realty and Banking Stocks Witness Buying(Closing)

Indian share markets continued to trade on a positive note during closing hours of trade and ended the day marginally higher.

Related Views on News

UNICHEM LAB Announces Quarterly Results (2QFY19); Net Profit Down 61.4% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, UNICHEM LAB has posted a net profit of Rs 177 m (down 61.4% YoY). Sales on the other hand came in at Rs 2 bn (down 42.6% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB Announces Quarterly Results (1QFY19); Net Profit Down 1479.6% (Quarterly Result Update)

Aug 3, 2018 | Updated on Aug 3, 2018

For the quarter ended June 2018, UNICHEM LAB has posted a net profit of Rs 207 m (down 1479.6% YoY). Sales on the other hand came in at Rs 2 bn (down 35.9% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

These Are the Kind of Blue Chips You Should Invest In(The 5 Minute Wrapup)

Nov 9, 2018

All blue chip companies are large caps but all large caps are not blue chips.

Get this Small Cap Logistics Company at a 16% Discount Right Now...(Profit Hunter)

Nov 6, 2018

If you turn the clock back, the current macroeconomic climate is nothing new. The markets have seen them all, and every downcycle has been succeeded by gravity defying gains...more so in the small cap space. This time will be no different.

Insider Buying: These Owner Operators Are Taking Advantage of the Correction(Chart Of The Day)

Nov 2, 2018

We believe insider buying is one of the strongest smart money indicators.

Are Fund Houses Opening Up Their NFO Factories Again?(Outside View)

Nov 2, 2018

PersonalFN sheds light on FY 2018-19 so far, the mutual fund industry has collectively launched 84 New Fund Offers (NFOs), of which some are still open for subscription.

Does it Make Sense to Invest in Offshore Funds?(Outside View)

Nov 6, 2018

Many investors prefer to invest in offshore funds because of the rupee depreciation and on-going downtrend in the markets, but it is to be invested only when there is no option available to invest in India.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Nov 15, 2018 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB - J.B.CHEMICALS COMPARISON

COMPARE UNICHEM LAB WITH

MARKET STATS